Skip to content

Study on the Effect of Target-controlled Infusion for General Anesthesia in Cardiac Surgery

Study on the Effect of Target-controlled Infusion of Propofol and Remifentanil for Patients Undergoing Cardiac Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06012955
Enrollment
2000
Registered
2023-08-28
Start date
2023-08-30
Completion date
2024-06-30
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Mechanical Ventilation Time

Brief summary

The purpose of the study was to evaluate whether individualized general anesthesia with target-controlled infusion could help patients wake up early for extubation and reduce the incidence of postoperative complications, and to investigate the effectiveness and safety of its application in patients undergoing cardiac surgery.

Interventions

DEVICETarget-controlled infusion (TCI) systems

Target-controlled infusion (TCI) with propofol and remifentanil was used for anesthesia induction and maintenance

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients aged 18 years and older who underwent cardiac surgery

Exclusion criteria

* Mechanical ventilation support before surgery; * Combined with any type of non-cardiac surgeries; * Second exploratory thoracotomy after surgery; * Died or discharged within 48 h after surgery; * Missing clinical data

Design outcomes

Primary

MeasureTime frameDescription
Duration of postoperative mechanical ventilation4 weeks after surgeryDuration of mechanical ventilation was defined as the time from the end of surgery to tracheal extubation

Countries

China

Contacts

Primary ContactQingping Wu
wqp1968@163.com13971605283

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026